VUTRISIRAN SODIUM | N215515 | ALNYLAM PHARMACEUTICALS INC
| Patent # | Expiration | PED | Drug Substance | Drug Product | Use Code | Delist |
|---|---|---|---|---|---|---|
| 8106022 | Dec 12, 2029 | — | Yes | Yes | — | |
| 8828956 | Dec 4, 2028 | — | Yes | Yes | — | |
| 9370581 | Dec 4, 2028 | — | Yes | Yes | — | |
| 9399775 | Nov 16, 2032 | — | Yes | Yes | — | |
| 10131907 | Aug 24, 2028 | — | Yes | Yes | — | |
| 10208307 | Jul 28, 2036 | — | Yes | Yes | — | |
| 10570391 | Nov 16, 2032 | — | Yes | Yes | — | |
| 10612024 | Aug 14, 2035 | — | Yes | Yes | — | |
| 10683501 | Jul 28, 2036 | — | Yes | Yes | — | |
| 10806791 | Dec 4, 2028 | — | Yes | — | — | — |
| 11286486 | Jul 28, 2036 | — | Yes | Yes | — | |
| 11401517 | Aug 14, 2035 | — | Yes | Yes | — | |
| 12049628 | Jul 28, 2036 | — | Yes | Yes | — |
| Code | Date | Status |
|---|---|---|
| I-964 | Mar 20, 2028 | Active |
| NCE | Jun 13, 2027 | < 1 year |
| ODE-212 | Jun 13, 2029 | Active |
| ODE-527 | Mar 20, 2032 | Active |